期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恶性肿瘤的表皮生长因子受体靶向治疗现状 被引量：1

下载PDF
导出
作者 侯亮 姜月华 詹臻
机构地区 南京中医药大学第一临床医学院
出处 《临床肿瘤学杂志》 CAS 2004年第3期314-317,共4页 Chinese Clinical Oncology
基金 国家自然科学基金资助 (项目号 :30 0 70 910 )
关键词 恶性肿瘤 表皮生长因子受体 靶向治疗 信号转导途径 单克隆抗体
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1Peter BJ.Tony H.Oncogenic kinase signalling [J].Nature,2001,411:355-365.
  • 2孔燕国,苏长保,任祖渊,王任直.脑膜瘤患者手术前后血清表皮生长因子受体的测定[J].中国医学科学院学报,2002,24(4):427-429. 被引量：1
  • 3Ciardiello F,Bianco R,Damiano V,et al.Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225[J].Clin Cancer Res,1999,5:909-916.
  • 4Schmidt M,Maurer-Gebhard M,Groner B,et al.Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors[J].Oncogene,1999,18:1711-1721.
  • 5Douglass EC.Devreelopment of ZD1839 in colorectal cancer[J].Semin Oncol,2003,30(3 Suppl 6):17-22.
  • 6Hidde J.Haisma,Jacques Grill,David T.Curiel,et al.Targeting of adenvoiral vectors through a Bispecific single-chain antibody[J].Cancer Gene Ther,2000,7:901-904.
  • 7Raymond M.R.Reza K,Ross G.C,et al.111 In-Labeled EGF Is Selectively Radiotoxic to Human Breast Cancer Cells Overexpressing EGFR[J].Nucl Med,2000,41:429-438.
  • 8Raymond M.R,Reza K,Jasbir S,et al.A Comparison of EGF and MAb 528 Labeled with 111 In for Imaging Human Breast Cancer[J].Nucl Med,200,41:903-911.
  • 9Xiaoxia W,Qing-Ping W,Shi K,et al.Conjugation with 111 In-DTPA-Poly(Ethylene Glycol)Improves Imaging of Anti-EGF Receptor Antibody C225[J].Nucl Med,2001,42:1530-1537
  • 10Seidman A,Hudis C,Pierri MK,et al.Cardiac dysfunction in the trastuzumab clinical trials experience[J].Clin Oncol,2002,20:1215-1221.

二级参考文献2

同被引文献26

  • 1李丹,曾波航,于宪.转化生长因子α和表皮生长因子在恶性肿瘤的表达[J].广州医学院学报,2001,29(4):20-22. 被引量：4
  • 2廖小金.表皮生长因子结构和生物学效应[J].海峡药学,2006,18(5):14-17. 被引量：21
  • 3刘浏,蔡以理.表皮生长因子受体及其单克隆抗体与口腔癌[J].口腔颌面外科杂志,2007,17(2):191-194. 被引量：2
  • 4Levi-Montalcini R,Cohen S. Effects of the extract of the mouse sub-maxillary salivary glands on the sympathetic system of mammals[J]. Ann N Y Acad Sci, 1960,85 :324 - 341.
  • 5Ongkeko WM, Altuna X, Weisman RA,et al. Expression of proteintyrosine kinases in head and neck squamous cell carcinomas[ J].Am J Clin Pathol, 2005,124( 1) :71 -76.
  • 6Kelloff GJ,Fay JR,Steele VE,et al. Epidermal growth factor recep-tor tyrosine kinase inhibitors as potential cancer chemopreventives[J]. Cancer Epidemiol Biomarkers Prev,1996,5(8) :657 -666.
  • 7Gibbons MD,Manne U,Carroll WR,et al. Molecular differences inmucoepidermoid carcinoma and adenoid cystic carcinoma of themajor salivary glands [ J ]. Laryngoscope, 2001,111 ( 8 ) : 1373-1378.
  • 8Kawamoto T,Takahashi K,Nishi M,et al. Quantitative assay of epi-dermal growth factor receptor in human squamous cell carcinomasof the oral region by an avidin-biotin method [ J ]. Jpn J CancerRes,1991,82(4) :403 -410.
  • 9Hendler FJ, Richards CS,Shum A, et al. Nuclear mechanisms forthe increase of epidermal growth factor receptor in squamous cellcarcinoma[ J]. Trans Assoc Am Physicians, 1985 ,98 : 189 — 197.
  • 10Fujino S,Enokibori T,Tezuka N,et al. A comparison of epidermalgrowth factor receptor levels and other prognostic parameters innon-small cell lungcancer [ J ]. Eur J Cancer, 1996,32A ( 12 ):2070-2074.

引证文献1

二级引证文献6

临床肿瘤学杂志
2004年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部